Literature DB >> 23680071

Determination of optimal cutoff value to accurately identify glucose-6-phosphate dehydrogenase-deficient heterozygous female neonates.

Jing-Kun Miao1, Qi-Xiong Chen, Li-Ming Bao, Yi Huang, Juan Zhang, Ke-Xing Wan, Jing Yi, Shi-Yi Wang, Lin Zou, Ting-Yu Li.   

Abstract

BACKGROUND: Conventional screening tests to assess G6PD deficiency use a low cutoff value of 2.10 U/gHb which may not be adequate for detecting females with heterozygous deficiency. The aim of present study was to determine an appropriate cutoff value with increased sensitivity in identifying G6PD-deficient heterozygous females.
METHODS: G6PD activity analysis was performed on 51,747 neonates using semi-quantitative fluorescent spot test. Neonates suspected with G6PD deficiency were further analyzed using quantitatively enzymatic assay and for common G6PD mutations. The cutoff values of G6PD activity were estimated using the receiver operating characteristic curve.
RESULTS: Our results demonstrated that using 2.10 U/g Hb as a cutoff, the sensitivity of the assay to detect female neonates with G6PD heterozygous deficiency was 83.3%, as compared with 97.6% using 2.55 U/g Hb as a cutoff. The high cutoff identified 21% (8/38) of the female neonates with partial G6PD deficiency which were not detected with 2.10 U/g Hb. Our study found that high cutoffs, 2.35 and 2.55 U/g Hb, would increase assay's sensitivity to identify male and female G6PD deficiency neonates, respectively.
CONCLUSIONS: We established a reliable cutoff value of G6PD activity with increased sensitivity in identifying female newborns with partial G6PD deficiency.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ARMS; Cut-off value; Female; G6PD; G6PD deficiency; Heterozygotes; Newborn screening; ROC; amplification refractory mutation system; glucose-6-phosphate-dehydrogenase; receiver operating characteristic

Mesh:

Substances:

Year:  2013        PMID: 23680071     DOI: 10.1016/j.cca.2013.05.004

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Application of genetic screening processor in screening neonatal glucose-6-phosphate dehydrogenase deficiency.

Authors:  Haixia Miao; Yu Zhang; Kexin Fang; Yezhen Shi; Ting Zhang; Rongqing Chen; Dingwen Wu; Rulai Yang; Xinwen Huang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-08-25

2.  G6PD Deficiency in an HIV Clinic Setting in the Dominican Republic.

Authors:  Julia Z Xu; Richard O Francis; Leonel E Lerebours Nadal; Maryam Shirazi; Vaidehi Jobanputra; Eldad A Hod; Jeffrey S Jhang; Brie A Stotler; Steven L Spitalnik; Stephen W Nicholas
Journal:  Am J Trop Med Hyg       Date:  2015-08-03       Impact factor: 2.345

3.  Newborn screening of glucose-6-phosphate dehydrogenase deficiency in Guangxi, China: determination of optimal cutoff value to identify heterozygous female neonates.

Authors:  Chunyun Fu; Shiyu Luo; Qifei Li; Bobo Xie; Qi Yang; Guoxing Geng; Caijuan Lin; Jiasun Su; Yue Zhang; Jin Wang; Zailong Qin; Jingsi Luo; Shaoke Chen; Xin Fan
Journal:  Sci Rep       Date:  2018-01-16       Impact factor: 4.379

4.  Glucose-6-phosphate dehydrogenase deficiency in the Han Chinese population: molecular characterization and genotype-phenotype association throughout an activity distribution.

Authors:  Ying He; Yinhui Zhang; Xionghao Chen; Qiong Wang; Lifen Ling; Yuhong Xu
Journal:  Sci Rep       Date:  2020-10-13       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.